Welcome to our dedicated page for Lifestance Health Group news (Ticker: LFST), a resource for investors and traders seeking the latest updates and insights on Lifestance Health Group stock.
LifeStance Health Group, Inc. (LFST) provides investors and industry observers with timely access to corporate developments through this centralized news hub. Track official press releases, regulatory filings, and strategic announcements from one of the nation's leading outpatient mental healthcare providers.
Key resources include: Earnings reports detailing financial performance, partnership announcements with healthcare networks, expansions of clinical services, and leadership updates. This curated collection serves as a primary source for understanding LFST's operational milestones and market positioning.
All content reflects the company's focus on evidence-based behavioral healthcare and its commitment to expanding access through innovative care models. Regular updates ensure stakeholders stay informed about developments in teletherapy advancements, clinical research collaborations, and regulatory compliance matters.
Bookmark this page for direct access to LFST's verified corporate communications, eliminating the need to search multiple sources. Check back frequently for updates on operational metrics, facility expansions, and other material events shaping the company's trajectory in mental healthcare.
LifeStance Health Group (Nasdaq: LFST) reported third-quarter 2025 results for the period ended September 30, 2025. Revenue rose 16% year-over-year to $363.8M driven by a 17% increase in visit volumes and an 11% increase in clinicians to 7,996. Adjusted EBITDA increased 31% to $40.2M (11.1% margin) and the company posted net income of $1.1M versus a prior-year loss. Center Margin grew 16% to $116.6M (32.0% of revenue). Cash from operations was $27.3M in Q3 with ending cash of $203.9M and net long-term debt of $269.4M. Full-year 2025 guidance reiterated for revenue $1.41B–$1.43B and raised Adjusted EBITDA to $146M–$152M.
LifeStance Health (NYSE:LFST) released a national survey on Nov. 5, 2025, measuring how the holiday season affects mental health. Key findings: 57% find the holidays stressful, 69% feel pressure to appear happier, and 51% report loneliness even when with loved ones. Younger adults are hardest hit: Millennials and Gen Z report the highest desire to skip events and the greatest pressure to perform emotionally.
The survey sampled 1,023 U.S. adults from Oct. 16–21, 2025, with a ±4 point credibility interval. LifeStance highlights access to flexible and remote outpatient care.
LifeStance Health (NYSE:LFST) released a national survey on Nov. 5, 2025, measuring how the holiday season affects mental health. Key findings: 57% find the holidays stressful, 69% feel pressure to appear happier, and 51% report loneliness even when with loved ones. Younger adults are hardest hit: Millennials and Gen Z report the highest desire to skip events and the greatest pressure to perform emotionally.
The survey sampled 1,023 U.S. adults from Oct. 16–21, 2025, with a ±4 point credibility interval. LifeStance highlights access to flexible and remote outpatient care.
LifeStance Health (NASDAQ: LFST) will present at the UBS Global Healthcare Conference in Palm Beach Gardens, FL on Monday, November 10, 2025 at 4:15 p.m. ET. CEO Dave Bourdon will present and the session will be moderated by Kevin Caliendo.
The presentation will be webcast live and a replay will be available in the Events and Presentations section of the LifeStance Health Investor Relations website.
Calm Health (LFST) announced a partnership with LifeStance Health on October 28, 2025 to streamline access to licensed mental health care. Calm Health users complete a screening and receive a personalized plan that can now refer higher‑acuity cases directly to LifeStance.
Key points: Calm Health is available to more than 26 million people; LifeStance operates across 550+ centers, offers virtual and in‑person therapy, accepts most insurance plans, and patients can typically schedule first appointments within one week or less.
Calm Health (LFST) announced a partnership with LifeStance Health on October 28, 2025 to streamline access to licensed mental health care. Calm Health users complete a screening and receive a personalized plan that can now refer higher‑acuity cases directly to LifeStance.
Key points: Calm Health is available to more than 26 million people; LifeStance operates across 550+ centers, offers virtual and in‑person therapy, accepts most insurance plans, and patients can typically schedule first appointments within one week or less.
LifeStance (NASDAQ: LFST) will release its third quarter 2025 earnings before markets open on Thursday, November 6, 2025. The company will host a live conference call the same day at 8:30 a.m. Eastern Time to discuss results.
Investors can join by dialing 1-800-715-9871 (U.S.) or 1-646-307-1963 (international) using conference ID 3958273, or listen via the real-time audio webcast on the LifeStance Investor Relations website where related materials and a replay will be posted.
LifeStance Health Group (NASDAQ: LFST), a leading outpatient mental health care provider, announced its participation in the 23rd Annual Morgan Stanley Global Healthcare Conference in New York City. CEO Dave Bourdon and CFO Ryan McGroarty will present on Tuesday, September 9, 2025, at 10:00 AM ET.
The presentation will be moderated by Craig Hettenbach and will be available via live webcast on the company's investor relations website, with a replay accessible after the event.
LifeStance Health (NASDAQ: LFST), a major outpatient mental health care provider, has announced the appointment of Sarah Personette to its board of directors, effective August 22, 2025. Personette, currently CEO of Puck, brings over 20 years of experience in customer experience and technology leadership, including previous roles as Chief Customer Officer at X (formerly Twitter) and COO of Refinery29.
The appointment coincides with the departure of William Miller, who is stepping down from the board after five years of service. Miller, who serves as Wellsky Chairman and CEO, has been recognized for his contributions to advancing LifeStance's organizational mission during his tenure.
LifeStance Health (NASDAQ: LFST), a major outpatient mental healthcare provider, reported strong Q2 2025 financial results. Revenue increased 11% to $345.3 million, driven by higher visit volumes and clinician growth. The company's clinician base grew 11% to 7,708 clinicians, with a net addition of 173 clinicians in Q2.
The company significantly reduced its net loss to $3.8 million from $23.3 million year-over-year, while achieving record free cash flow of $56.6 million. Adjusted EBITDA grew 19% to $34.0 million. For FY 2025, LifeStance reiterated revenue guidance of $1.40-1.44 billion and raised Adjusted EBITDA expectations to $140-150 million.
FAQ
What is the current stock price of Lifestance Health Group (LFST)?
What is the market cap of Lifestance Health Group (LFST)?
